High prevalence of femoral head necrosis in Mucopolysaccharidosis type III (Sanfilippo disease): a national, observational, cross-sectional study (Q43804105)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 March 2013

Language	Label	Description	Also known as
English	High prevalence of femoral head necrosis in Mucopolysaccharidosis type III (Sanfilippo disease): a national, observational, cross-sectional study	scientific article published on 16 March 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

High prevalence of femoral head necrosis in Mucopolysaccharidosis type III (Sanfilippo disease): a national, observational, cross-sectional study (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sanfilippo syndrome

1 reference

based on heuristic

inferred from title

author name string

Jessica de Ruijter

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Mario Maas

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Anneloes Janssen

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Frits A Wijburg

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

16 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Molecular Genetics and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

109

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

49-53

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sanfilippo syndrome: a mini-review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Therapy for the mucopolysaccharidoses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Bone, joint and tooth development in mucopolysaccharidoses: Relevance to therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler-Scheie syndrome (mucopolysaccharidosis type I).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Mucopolysaccharidosis VI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Orthopedic manifestations in patients with mucopolysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome Survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Femoral head dysplasia in Morquio disease type A: bilateral varus osteotomy of the femur.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Musculoskeletal Manifestations of Sanfilippo Syndrome (Mucopolysaccharidosis Type III)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Secondary storage of dermatan sulfate in Sanfilippo disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Pathogenesis of skeletal and connective tissue involvement in the mucopolysaccharidoses: glycosaminoglycan storage is merely the instigator

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Pathophysiology and new strategies for the treatment of Legg-Calvé-Perthes disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Legg-Calvé-Perthes disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.004

7 January 2021

Heparan sulfate derived disaccharides in plasma and total urinary excretion of glycosaminoglycans correlate with disease severity in Sanfilippo disease

1 reference

9 November 2024

https://opencitations.net/index/api/v1/citations/10.1007/S10545-012-9535-5

Identifiers

10.1016/J.YMGME.2013.03.004

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43804105&oldid=2272338104"